These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15571606)

  • 1. Disseminated primary varicella after initiation of infliximab for Crohn's disease.
    Leung VS; Nguyen MT; Bush TM
    Am J Gastroenterol; 2004 Dec; 99(12):2503-4. PubMed ID: 15571606
    [No Abstract]   [Full Text] [Related]  

  • 2. Extra-intestinal Hodgkin's lymphoma in a Crohn's disease patient on long-term azathioprine and infliximab therapy.
    Dahhan T; Al Kahtani K; Bakshi N; Abouzied ME; Helmy A
    Trop Gastroenterol; 2010; 31(1):51-3. PubMed ID: 20860231
    [No Abstract]   [Full Text] [Related]  

  • 3. Induction of pustular lesions during infliximab therapy for Crohn's disease.
    Pérez-Pérez L; Caeiro JL; Fabeiro JM; Allegue F; Zulaica A
    Acta Derm Venereol; 2008; 88(3):292-3. PubMed ID: 18480940
    [No Abstract]   [Full Text] [Related]  

  • 4. Infliximab treatment and pregnancy outcome in active Crohn's disease.
    Srinivasan R
    Am J Gastroenterol; 2001 Jul; 96(7):2274-5. PubMed ID: 11467677
    [No Abstract]   [Full Text] [Related]  

  • 5. Onset of flexural psoriasis during infliximab treatment for Crohn's disease.
    Peramiquel L; Puig L; Dalmau J; Ricart E; Roe E; Alomar A
    Clin Exp Dermatol; 2005 Nov; 30(6):713-4. PubMed ID: 16197398
    [No Abstract]   [Full Text] [Related]  

  • 6. Colon cancer after infliximab therapy for Crohn's disease in a young patient transplanted for primary sclerosing cholangitis.
    Peyrin-Biroulet L; Bressenot A; Chone L; Denjean P; Boissel P; Bigard MA; Bronowicki JP
    Am J Gastroenterol; 2006 Nov; 101(11):2664-5. PubMed ID: 17090288
    [No Abstract]   [Full Text] [Related]  

  • 7. [Early obstructive colon after treatment of active refractory Crohn's disease with infliximab].
    Belaiche J; Louis E
    Gastroenterol Clin Biol; 2003 Nov; 27(11):1045-7. PubMed ID: 14732856
    [No Abstract]   [Full Text] [Related]  

  • 8. Development of diffuse psoriasis with alopecia during treatment of Crohn's disease with infliximab.
    Medkour F; Babai S; Chanteloup E; Buffard V; Delchier JC; Le-Louet H
    Gastroenterol Clin Biol; 2010 Feb; 34(2):140-1. PubMed ID: 20138448
    [No Abstract]   [Full Text] [Related]  

  • 9. Transient type III atrioventricular block after infliximab infusion in a fistulizing perianal Crohn's disease patient.
    Sofos S; Savoye G; Ramirez S; Bauer F; Lerebours E
    Am J Gastroenterol; 2007 Jan; 102(1):217-9. PubMed ID: 17278277
    [No Abstract]   [Full Text] [Related]  

  • 10. Complications of infliximab therapy in children and adolescents affected by Crohn's disease.
    Diamanti A; Papadatou B; Knafelz D; Gambarara M; Ferretti F; Castro M
    Am J Gastroenterol; 2003 Dec; 98(12):2812-3. PubMed ID: 14687847
    [No Abstract]   [Full Text] [Related]  

  • 11. [Indications and results of infliximab in Crohn's disease].
    Karoui S; Boubaker J; Filali A
    Tunis Med; 2004 Dec; 82(12):1057-63. PubMed ID: 15822505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute paraplegia after the initiation of anti-tumour necrosis factor-alpha therapy for Crohn's disease.
    Vadikolias K; Kouklakis G; Heliopoulos I; Argyropoulou P; Papanas N; Tzilonidou M; Prassopoulos P; Piperidou H
    Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):159-62. PubMed ID: 17273002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pneumocystis pneumonia during infliximab treatment for active Crohn's colitis].
    Minnee RC; Stokkers P; Riemens SC; Hommes DW
    Ned Tijdschr Geneeskd; 2005 Oct; 149(41):2290-5. PubMed ID: 16240855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical challenges and images in GI. Oral lichenoid reaction in a patient with Crohn's disease receiving infliximab.
    Moss AC; Treister NS; Marsee DK; Cheifetz AS
    Gastroenterology; 2007 Feb; 132(2):488, 829. PubMed ID: 17261307
    [No Abstract]   [Full Text] [Related]  

  • 15. Infliximab: lifetime use for maintenance is appropriate in Crohn's Disease. CON: "lifetime use" is an awfully long time.
    Loftus EV
    Am J Gastroenterol; 2005 Jul; 100(7):1435-8. PubMed ID: 15984960
    [No Abstract]   [Full Text] [Related]  

  • 16. Infliximab: lifetime use for maintenance is appropriate in Crohn's Disease. PRO: maintenance therapy is superior to episodic therapy.
    Lichtenstein GR
    Am J Gastroenterol; 2005 Jul; 100(7):1433-5. PubMed ID: 15984959
    [No Abstract]   [Full Text] [Related]  

  • 17. [Severe varicella infection during treatment with infliximab for Crohn's disease].
    Tougeron D; Mauillon J; Tranvouez JL
    Gastroenterol Clin Biol; 2006 Dec; 30(12):1410-3. PubMed ID: 17211344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Timing infliximab therapy in pediatric Crohn's disease.
    Kirschner BS; Huo D
    Gastroenterology; 2007 Mar; 132(3):1167-70. PubMed ID: 17383435
    [No Abstract]   [Full Text] [Related]  

  • 19. Disseminated tuberculosis in a Crohn's disease patient on anti-TNF alpha therapy despite chemoprophylaxis.
    Bourikas LA; Kourbeti IS; Koutsopoulos AV; Koutroubakis IE
    Gut; 2008 Mar; 57(3):425; author reply 425-6. PubMed ID: 18268059
    [No Abstract]   [Full Text] [Related]  

  • 20. [Fulminant acute hepatitis B after infliximab treatment in Crohn's disease].
    Olfa H; Aroua G; Wissem M; Wafa BM; Hichem L; Nabil BC; Fethia B; Leila S
    Tunis Med; 2014 May; 92(5):349-50. PubMed ID: 25504398
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.